Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,298 papers from all fields of science
Search
Sign In
Create Free Account
Receptor Tyrosine Kinase Inhibition
Known as:
Tyrosine Kinase Receptor Inhibition
A process that negatively regulates the intracellular catalytic activities that originate with the binding of a tyrosine kinase-associated…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
AXL Inhibitor BGB324
Allosteric Bcr-Abl Tyrosine Kinase Inhibitor ABL001
BMS 599626
BMS 777607
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
INFLUENCE OF DIFFERENT CELL STORAGE/CULTURE CONDITIONS ON SPONTANEOUS PROLIFERATION AND LEVEL OF TYROSINE KINASE RECEPTOR INHIBITION IN TWO FELINE INJECTION-SITE SARCOMA CELL LINES
Brittany R Feldhaeusser
,
M. Turek
,
J. Lawrence
,
K. Cornell
,
R. Gogal
Journal of immunoassay & immunochemistry
2013
Corpus ID: 26120449
Optimizing cell culture conditions is important when studying cell proliferation and viability, particularly in response to…
Expand
2012
2012
Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.
Smit Singla
,
J. Pippin
,
J. Drebin
Oncology Report
2012
Corpus ID: 10225746
Patient survival in pancreatic cancer remains poor with gemcitabine (GEM)-based regimens. The target specific…
Expand
Review
2011
Review
2011
Multitargeted receptor tyrosine kinase inhibition: an antiangiogenic strategy in non-small cell lung cancer.
M. Socinski
Cancer Treatment Reviews
2011
Corpus ID: 9579541
2010
2010
The contribution of a 2-amino group on receptor tyrosine kinase inhibition and antiangiogenic activity in 4-anilinosubstituted pyrrolo[2,3-d]pyrimidines.
A. Gangjee
,
Ojas A. Namjoshi
,
M. Ihnat
,
Aaron Buchanan
Bioorganic & Medicinal Chemistry Letters
2010
Corpus ID: 2252670
2008
2008
Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition.
A. Bozec
,
F. Gros
,
+6 authors
G. Milano
European Journal of Cancer
2008
Corpus ID: 28811010
2005
2005
M 1 – 004 Receptor tyrosine kinase inhibition in cancer therapy : from monospecific to multi-targeted drugs
A. Yoshimori
,
R. Takasawa
,
+17 authors
B. Kobe
2005
Corpus ID: 53477908
Cancer cells develop strong anti-apoptotic signaling pathways and therefore escape many therapeutic regimens. Recognizing this…
Expand
Highly Cited
2004
Highly Cited
2004
Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats.
V. Torres
,
W. Sweeney
,
+4 authors
E. Avner
Kidney International
2004
Corpus ID: 10194129
BACKGROUND Advances in the understanding of cystogenesis, identification of the PKHD1 gene and availability of a rat model (the…
Expand
Review
2003
Review
2003
The role of receptor tyrosine kinase inhibition in treating gastrointestinal malignancy
Mary Anderson
,
J. Jankowski
Expert Opinion on Investigational Drugs
2003
Corpus ID: 38161514
Tyrosine kinase receptors are proteins that transduce the signal from many growth factor and cytokine ligands to produce…
Expand
2000
2000
Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro.
S. Naraghi
,
S. Khoshyomn
,
J. Demattia
,
D. Vane
Journal of Pediatric Surgery
2000
Corpus ID: 33746971
PURPOSE Children who undergo standard therapy for renal tumors are at an increased risk for treatment sequelae such as congestive…
Expand
1996
1996
Genistein suppresses EGF-induced prostaglandin biosynthesis by a mechanism independent of EGF receptor tyrosine kinase inhibition.
D. Kniss
,
P. Zimmerman
,
H. Su
,
R. Fertel
Prostaglandins
1996
Corpus ID: 45390365
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE